Bal Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has submitted a routine compliance certificate to the stock exchanges (NSE and BSE) under Regulation 74(5) of SEBI's Depositories and Participants Regulations. The company, based on certificates received from its Registrar & Transfer Agent (MUFG Intime India Pvt Ltd), has confirmed that details of all securities dematerialized or rematerialized during the quarter ended 31 December 2025 were furnished to the stock exchanges within the prescribed time limit. Share certificates received for dematerialization were mutilated and cancelled, and the depository's name was substituted as the registered owner within 15 days of receipt, as required. This is a standard regulatory filing with no business or financial figures disclosed.
This is a routine procedural compliance filing with no material impact on shareholders or the stock price. It simply confirms the company is meeting its regulatory obligations regarding share dematerialization records.